Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
omega-3 fatty acids + vitamin E (Rivchem Pharmaceuticals)
- Development stage
- Unknown
- Lead developer
- Rivchem Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Rivcod (also known as Rivcod-400) is an oral combination dietary supplement developed and marketed by Rivchem Pharmaceuticals. It is formulated as a softgel capsule containing omega-3 fatty acids (500 mg) and vitamin E (400 IU). Omega-3 fatty acids act as agonists of free fatty acid receptor 4 (FFA4) and peroxisome proliferator-activated receptor alpha (PPAR-alpha), which helps lower triglyceride levels, reduce inflammation, and support cardiovascular health. Vitamin E acts as a lipid-soluble antioxidant, scavenging reactive oxygen species (ROS) to protect cell membranes from oxidative damage and support immune function. Rivcod is primarily indicated for the treatment of nutritional deficiencies, coronary artery disease, skin disorders, fibrocystic breast disease, muscle cramps, and intermittent claudication.
- Brand names
- RivcodRivcod-400Rivcod400Rivcod 400
- Other names
- omega-3 fatty acid + vitamin Eomega-3 fatty acids + vitamin E acetate
02
Targets
FFAR4 (Free fatty acid receptor 4)PPARA (Peroxisome proliferator-activated receptor alpha)
Beyond the preview
Go deeper on omega-3 fatty acids + vitamin E (Rivchem Pharmaceuticals).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on omega-3 fatty acids + vitamin E (Rivchem Pharmaceuticals).